AngioDynamics reports FY2027 first-quarter financial results

AngioDynamics, Inc. (NASDAQ:ANGO) said it announced financial results for the first quarter of FY2027. The company described itself as a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.